A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease (NCT03251118)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (37 Sites)

Showing the first 25 of 37 sites.

• Om Research — Lancaster, California
• FACEY Medical Foundation — Mission Hills, California
• University of California - Davis — Sacramento, California
• Stanford University — Stanford, California
• University of Colorado Denver — Aurora, Colorado
• Gastro Florida — Clearwater, Florida
• University of Florida Health Jacksonville-Gastroenterology — Jacksonville, Florida
• Advanced Gastroenterology Associates, LLC — Palm Harbor, Florida
• Atlanta Gastro — Atlanta, Georgia
• The University of Chicago Medical Center — Chicago, Illinois
• Indianapolis Gastroenterology Research Foundation — Indianapolis, Indiana
• University of Iowa Hospitals and Clinics — Iowa City, Iowa
• Gastroenterology Associates — Baton Rouge, Louisiana
• Louisiana Research Center, LLC — Shreveport, Louisiana
• University of Michigan Medical Center — Ann Arbor, Michigan
• University of Minnesota — Minneapolis, Minnesota
• Saint Louis University — St Louis, Missouri
• University of Nebraska Medical Center — Omaha, Nebraska
• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire
• Rutgers, Robert Wood Johnson Medical School — New Brunswick, New Jersey
• NYU Langone Health — New York, New York
• Mount Sinai, Icahn School of Medicine — New York, New York
• Premier Medical Group of the Hudson Valley — Poughkeepsie, New York
• The Children's Hospital at Montefiore — The Bronx, New York
• Cary Gastroenterology Associates — Cary, North Carolina

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Inflammatory Bowel Diseases

• Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care — Vancouver, British Columbia
• PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial — Ottawa, Ontario
• A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy — Baltimore, Maryland
• Outpatient VR (Virtual Reality)-Brain-gut Behavioral Therapies (BGBT) in Inflammatory Bowel Disease (IBD) — Ann Arbor, Michigan
• A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC — Sun City, Arizona

Explore by condition: All Inflammatory Bowel Diseases clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.